Vivo Surgical
Kevin Koh, PhD, is a distinguished entrepreneur and leader in the biotechnology and medical technology sectors, currently serving as the Founder and CEO of Vivo Surgical Private Limited, where KLARO®, an innovative surgical lighting device, was launched. Koh holds significant roles, including Member of the Governing Board at TÜV Rheinland Group, Chairman and Board Member at PathoVax LLC, and Director at VerImmune, advancing cancer immunotherapy. As Co-Founder and Director of the Metropolitan Festival Orchestra, Koh has pioneered live movie-concert performances in Asia. Formerly, Koh founded Vivo Diagnostics Pte Ltd, led strategy at Ideal Electric Singapore Pte Ltd, and provided consulting services at MZ Advisory Pte Ltd, showcasing an extensive background in business development, advisory, and research commercialization. Koh's academic credentials include a PhD in Biomedical Engineering from Imperial College London and a BSc in Molecular Cell Biology from UCL.
This person is not in any teams
This person is not in any offices
Vivo Surgical
Vivo Surgical is a patient-focused, clinician-driven medical device developer and manufacturer. Headquartered in Singapore with a commercial presence in over 20 international territories, the company is pioneering a novel endoscopic surgical robot for complex endoluminal surgeries in the gastrointestinal tract. ISO 13485 certified with international accreditations awarded such as the US FDA and European CE mark, the company’s unique devices target the medical needs of the world through innovative applications of science & technology. Currently, Vivo Surgical’s proprietary technologies encompass fields such as in vivo surgical LED lighting, portable endoscopy and flexible endoscopic robotics.